Altrafin AG’s Citigroup C Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-21,200
Closed -$1.34M 61
2024
Q1
$1.34M Hold
21,200
0.49% 43
2023
Q4
$1.09M Sell
21,200
-21,000
-50% -$930K 0.42% 44
2023
Q3
$1.74M Hold
42,200
0.76% 38
2023
Q2
$1.94M Buy
42,200
+2,000
+5% +$93.7K 0.87% 34
2023
Q1
$1.88M Buy
40,200
+8,000
+25% +$393K 0.93% 32
2022
Q4
$1.46M Hold
32,200
0.85% 33
2022
Q3
$1.34M Hold
32,200
0.8% 36
2022
Q2
$1.48M Buy
32,200
+5,000
+18% +$250K 0.8% 37
2022
Q1
$1.45M Sell
27,200
-2,800
-9% -$173K 0.57% 41
2021
Q4
$1.81M Buy
+30,000
New +$1.99M 0.65% 43

Other funds holding C

Altrafin AG's C Position: Q2 2024 in Review

Altrafin AG sold out of Citigroup (C) in Q2 2024, closing a stake of 21,200 shares — an estimated $1.34M sold.

Altrafin AG first reported a position in C in Q4 2021 and held it in 10 quarters. The position peaked at $1.94M in Q2 2023. 1,782 funds tracked by Wall St. Rank hold C as of Q2 2024.

  • Altrafin AG reported no remaining Citigroup position as of Q2 2024 after selling out during the quarter.
  • Altrafin AG sold 21,200 Citigroup shares in Q2 2024, an estimated $1.34M.
  • Altrafin AG first reported a position in Citigroup in Q4 2021 and held it in 10 quarters.
  • Altrafin AG's Citigroup position peaked at $1.94M in Q2 2023.
  • 1,782 funds tracked by Wall St. Rank held Citigroup as of Q2 2024.

Based on Altrafin AG's 13F filing for Q2 2024, filed 17 Feb 2026.